Clinical trial
Post-Market Clinical Follow-up Study to Monitor Device Performance and Outcomes of the CENTERA Transcatheter Heart Valve System
NCT03699345 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Clinical Follow-up Study to Monitor Device Performance and Outcomes of the CENTERA Transcatheter Heart Valve System
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 7, 2019
- Completion date
- August 20, 2024
- Enrollment
- 87 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.